Aptamer Sciences hit the upper price limit in early trading on July 3. The news that Aribio is seeking to acquire the company appears to have sparked investor interest.
As of 9:26 a.m. on this day, Aptamer Sciences shares were up by the daily maximum of 29.99% on the KOSDAQ market, trading at 1,634 won. The stock immediately reached the upper price limit as soon as the market opened.
On this day, it was reported that Aribio, a company developing treatments for dementia, recently expressed its intention to acquire Aptamer Sciences. Aribio had previously attempted to enter the KOSDAQ market through a technology-based special listing but failed multiple times. As a result, there is speculation that Aribio is pursuing the acquisition of Aptamer Sciences as a means of backdoor listing. Aptamer Sciences was listed on the KOSDAQ market in September 2020.
![[Market Focus] Aptamer Sciences Hits Upper Price Limit on News of Aribio Acquisition Attempt](https://cphoto.asiae.co.kr/listimglink/1/2025070209292929984_1751416169.jpg)
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
